References
- Masur H, Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med 1993; 329: 898–904
- Shafran SD, Deschěnes J, Miller M, Phillips P, Toma E. Uveitis and pseudojaundice during a regimen of clarithromcin. rifabutin, and ethambutol. N Engl J Med 1994; 330: 438–439
- Frank MO, Graham MB, Wispelway B. Rifabutin and uveitis. N Engl J Med 1994; 330: 868
- Fuller JD, Stanfield L ED, Craven DE. Rifabutin prophylaxis and uveitis. N Engl J Med 1994; 330: 1315–1316
- Havlir D, Torriani F, Dubé M. Uveitis associated with rifabutin prophylaxis. Ann Intern Med 1992; 121: 510–512
- Siegal FP, Eilbott D, Burger H, Gehan K, Davidson B, Kaell AT, Weiser B. Dose-limiting toxicity of rifabutin in AIDS-related complex: syndrome of arthralgia/arthritis. AIDS 1990; 4: 433–441
- Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993; 329: 828–833
- CDC. Uveitis associated with rifabutin therapy. MMWR 1994; 43: 658
- Narang PK, Trapnell GB, Schoenfelder JR, Lavelle JP, Bianchine JR. Fluconazole and enhanced effect of rifabutin prophylaxis. N Engl J Med 1994; 330: 1316–1317